BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND RBM10, GPATC9, 8241, ENSG00000182872, CTD-2522E6_5, GPATCH9, KIAA0122, P98175, MGC1132, DXS8237E, ZRANB5, MGC997 AND Treatment
9246 results:

  • 1. Metastatic Merkel Cell Carcinoma After Simultaneous Pancreas-kidney Transplantation: Fatal Outcomes.
    Burke O; Labib A; Burke G; Beer J; Nichols A
    J Drugs Dermatol; 2024 May; 23(5):376-379. PubMed ID: 38709686
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Does depressurization of the portal vein before liver transplantation affect the recurrence of HCC? A nested case-control study.
    Wei G; Zhao Y; Feng S; Yuan J; Xu G; Lv T; Yang J; Kong L; Yang J
    BMC Cancer; 2024 May; 24(1):558. PubMed ID: 38702621
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comparison of skin cancer risk between renal transplant recipients and patients with glomerular diseases in rural Queensland.
    Thet Z; Lam AK; Ng SK; Aung SY; Han T; Ranganathan D; Newsham S; Borg J; Pepito C; Khoo TK
    Aust J Rural Health; 2024 Apr; 32(2):249-262. PubMed ID: 38646861
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A phase I trial of autologous RAK cell immunotherapy in metastatic renal cell carcinoma.
    Xu J; Zhang W; Tong J; Liu C; Zhang Q; Cao L; Yu J; Zhou A; Ma J
    Cancer Immunol Immunother; 2024 Apr; 73(6):107. PubMed ID: 38642109
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identifying predictors of COVID-related delays in cancer-specific medical care.
    Greteman BB; Del Vecchio NJ; Garcia-Auguste CJ; Kahl AR; Gryzlak BM; Chrischilles EA; Charlton ME; Nash SH
    Cancer Med; 2024 Apr; 13(8):e7183. PubMed ID: 38629238
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Long-term outcome of pediatric renal transplantation with donors younger than 6 years.
    Ramirez-Amoros C; San Basilio M; Amesty V; Rivas S; Lobato R; Fernandez-Camblor C; Lopez-Pereira P; Martinez-Urrutia MJ
    Pediatr Transplant; 2024 May; 28(3):e14761. PubMed ID: 38628086
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Immunotherapy utilization patterns in patients with advanced cancer and autoimmune disease.
    Li H; Huntington S; Gross C; Wang SY
    PLoS One; 2024; 19(4):e0300789. PubMed ID: 38625861
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Ablation of kidney tumors in Patients with Substantial kidney Impairment: Current Status.
    Iguchi T; Matsui Y; Tomita K; Uka M; Umakoshi N; Kawabata T; Gobara H; Araki M; Hiraki T
    Curr Oncol Rep; 2024 May; 26(5):573-582. PubMed ID: 38625653
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. PSAT1 enhances the efficacy of the prognosis estimation nomogram model in stage-based clear cell renal cell carcinoma.
    Wang J; He X; Mi Y; Chen YQ; Li J; Wang R
    BMC Cancer; 2024 Apr; 24(1):463. PubMed ID: 38614981
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Pazopanib stimulates senescence of renal carcinoma cells through targeting nuclear factor E2-related factor 2 (Nrf2).
    Wang X; Yang J; Li D; Teng L; Chen Y; Meng J; Yang C; Yin Z; Li C
    J Biochem Mol Toxicol; 2024 Apr; 38(4):e23689. PubMed ID: 38613465
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A).
    Atkins MB; Jegede OA; Haas NB; Mcdermott DF; Bilen MA; Stein M; Sosman J; Alter R; Plimack ER; Ornstein MC; Hurwitz M; Peace DJ; Einstein D; Catalano PJ; Hammers H; Regan MM
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38604810
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Robotic salvage partial nephrectomy following surgical and ablative therapies.
    Feng CL; Franco A; Ditonno F; Manfredi C; Chow AK; Autorino R
    Int Braz J Urol; 2024; 50(3):373-374. PubMed ID: 38598832
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical safety and efficacy of microwave ablation for small renal masses.
    Foret A; Haaga CB; Jain S; Baumgartner CO; Escott M; Henderson BR; O'Brien ST; Delacroix SE; Gills JRR; Westerman ME
    Int Braz J Urol; 2024; 50(3):277-286. PubMed ID: 38598830
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Discussion on the surgical timing of rupture and hemorrhage of renal angiomyolipoma].
    Chen K; Deng S; Liu Z; Zhang H; Ma L; Zhang S
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Apr; 56(2):326-331. PubMed ID: 38595253
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Conversion to Radical Nephrectomy From Robotic Partial Nephrectomy Is Most Commonly Due to Anatomic and Oncologic Complexity.
    Wang Y; Wilder S; Butaney M; Hijazi M; Gandham D; Van Til M; Goldman B; Qi J; Mirza M; Johnson A; Rudoff M; Wenzler D; Rogers CG; Lane BR
    J Urol; 2024 May; 211(5):669-676. PubMed ID: 38591701
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Challenges and technical aspects in the management of muscle invasive bladder cancer as retrograde radical cystectomy with ileal conduit.
    Nusrat NB; Rehman AU; Zafar N; Muhammad S; Bajwa SI; Imtiaz S
    J Pak Med Assoc; 2024 Mar; 74(3):513-518. PubMed ID: 38591289
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Enhanced Theranostic Efficacy of
    Chen Z; Yang Q; Song L; Qiu Y; Wang T; Wu S; Huang W; Sun X; Wang A; Kang L
    Mol Pharm; 2024 May; 21(5):2544-2554. PubMed ID: 38588328
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Thoracoscopic treatment of mediastinal ectopic parathyroid adenomas: a Latinamerica experience case series and literature review.
    Karla Veronica C; Mariana CT; Adriana Graciela PR; Gabino CP; Francina Valezka BM
    J Cardiothorac Surg; 2024 Apr; 19(1):177. PubMed ID: 38575949
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
    Machiels JP; Tao Y; Licitra L; Burtness B; Tahara M; Rischin D; Alves G; Lima IPF; Hughes BGM; Pointreau Y; Aksoy S; Laban S; Greil R; Burian M; Hetnał M; Delord JP; Mesía R; Taberna M; Waldron JN; Simon C; Grégoire V; Harrington KJ; Swaby RF; Zhang Y; Gumuscu B; Bidadi B; Siu LL;
    Lancet Oncol; 2024 May; 25(5):572-587. PubMed ID: 38561010
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Efficacy of radiofrequency ablation vs. transcatheter arterial embolization for hepatic hemangiomas.
    Li J; Zhang S; Ning C; Li G; Guo S
    Eur J Gastroenterol Hepatol; 2024 Jun; 36(6):750-757. PubMed ID: 38555605
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 463.